Founder Directory
Built by Keitoto
Founders3
Known for these resultsRole0%Role is parsed from founder titles in yc.db. Known for 0% of these rows — the rest have no title at all, mostly 2019–2023. Those rows stay in the result and are counted as Unknown, never as No.Bio100%Bio coverage: 100% of these founders have a bio on their YC profile. Every bio-derived facet (ex-company, school, credentials, discipline) is Unknown for the rest.Ex-company0%Ex-company is matched from bios with employment context (ex-, formerly, worked at). 0% of these rows have at least one match.School100%School is matched from bios, case-sensitive for acronyms. 100% of these rows have at least one match.
- Alla ArzumanyanFounder · SFA TherapeuticsS21Healthcare · Philadelphia
- Ira SpectorFounder · SFA TherapeuticsS21Healthcare · Philadelphia
- Mark Feitelson@feitelsonFounder · SFA TherapeuticsS21Healthcare · Philadelphia
FOUNDERROLEBATCHINDUSTRYLOCATIONTEAMX_url
Alla ArzumanyanSFA TherapeuticsFounderSummer 2021HealthcarePhiladelphia, United States4—Ira SpectorSFA TherapeuticsFounderSummer 2021HealthcarePhiladelphia, United States4—Mark FeitelsonSFA TherapeuticsFounderSummer 2021HealthcarePhiladelphia, United States4https://x.com/feitelson
Showing 1–3 of 3 founders
Ira Spector
Founder·SFA Therapeutics
PRIMARY INFO
RoleFounder· not in title
Team size4
BatchSummer 2021
LocationPhiladelphia, United States
Company statusActive
StageEarly
BIO
Dr. Spector is the co-founder of SFA, a microbiome-derived pharmaceutical company focused on new advancements in the treatment inflammatory diseases. An experienced drug developer with over 30 years of experience, he helped develop 34 drugs and 12 medical devices, including Enbrel, Effexor, Protonix, Prevenar, Ozurdex, Botox for Overactive Bladder, Chronic Migraine and Cerebral Palsy. He holds BS degrees in Physics and EE from Washington University, an MBA from Drexel, and a PhD from Rutgers.
Ex-company, school and discipline below are derived from this bio. Nothing is inferred when the bio is missing.
BACKGROUND
CredentialsPhDMBA
DisciplineResearcherKeyword match from the bio text, not a classifier.
TRACK RECORD
First YC company on record
COMPANY CONTEXT
SFA TherapeuticsRegulating the immune system to block cancer & autoimmune diseases
IndustryHealthcare
Websitesfatherapeutics.com/
Team size4
LocationPhiladelphia, United States
BatchSummer 2021
